Index by author

November 01, 2023; Volume 90,Issue 11

  1. Gadegbeku, Crystal

    1. The new GFR equations: How will eliminating the race coefficient affect Black patients?
      Paul Merchant, MD, Crystal Gadegbeku, MD, FAHA, FACP, FASN, Ali Mehdi, MD, Med, FACP, FASN, George Thomas, MD, FACP, Georges Nakhoul, MD, MEd and Jonathan Taliercio, DO, FASN
      Cleveland Clinic Journal of Medicine November 2023, 90 (11) 685-691; DOI: https://doi.org/10.3949/ccjm.90a.22061

      The authors discuss the history of equations for the glomerular filtration rate and potential clinical consequences of the new equations.

  2. Goldar, Ghazaleh

    1. Cirrhosis: Primary care approaches to screening, immunization, and lifestyle modifications
      Cirrhosis: Primary care approaches to screening, immunization, and lifestyle modifications
      Asim Kichloo, MD, Michael Aljadah, MD, Michael Albosta, MD, Zain El-Amir, MD, Ghazaleh Goldar, MD, Muhammed Zatmar Khan, MD, Dushyant Singh Dahiya, MD and Farah Wani, MD
      Cleveland Clinic Journal of Medicine November 2023, 90 (11) 693-701; DOI: https://doi.org/10.3949/ccjm.90a.21043

      The authors review management of cirrhosis and complications such as esophageal varices and hepatocellular carcinoma, as well as chemical and medication exposures.

  3. Kapoor, Aanchal

    1. What is the role for terlipressin in hepatorenal syndrome?
      Stephanie N. Bass, PharmD, Aanchal Kapoor, MD and Christina C. Lindenmeyer, MD
      Cleveland Clinic Journal of Medicine November 2023, 90 (11) 664-667; DOI: https://doi.org/10.3949/ccjm.90a.23037

      The drug is recommended as a first-line treatment of hepatorenal syndrome-related acute kidney injury, but it is associated with respiratory failure, especially in the setting of albumin administration, and certain comorbidities may increase the risk.

  4. Khan, Muhammed Zatmar

    1. Cirrhosis: Primary care approaches to screening, immunization, and lifestyle modifications
      Cirrhosis: Primary care approaches to screening, immunization, and lifestyle modifications
      Asim Kichloo, MD, Michael Aljadah, MD, Michael Albosta, MD, Zain El-Amir, MD, Ghazaleh Goldar, MD, Muhammed Zatmar Khan, MD, Dushyant Singh Dahiya, MD and Farah Wani, MD
      Cleveland Clinic Journal of Medicine November 2023, 90 (11) 693-701; DOI: https://doi.org/10.3949/ccjm.90a.21043

      The authors review management of cirrhosis and complications such as esophageal varices and hepatocellular carcinoma, as well as chemical and medication exposures.

  5. Kichloo, Asim

    1. Cirrhosis: Primary care approaches to screening, immunization, and lifestyle modifications
      Cirrhosis: Primary care approaches to screening, immunization, and lifestyle modifications
      Asim Kichloo, MD, Michael Aljadah, MD, Michael Albosta, MD, Zain El-Amir, MD, Ghazaleh Goldar, MD, Muhammed Zatmar Khan, MD, Dushyant Singh Dahiya, MD and Farah Wani, MD
      Cleveland Clinic Journal of Medicine November 2023, 90 (11) 693-701; DOI: https://doi.org/10.3949/ccjm.90a.21043

      The authors review management of cirrhosis and complications such as esophageal varices and hepatocellular carcinoma, as well as chemical and medication exposures.

  6. Latifi, Mani

    1. COVID-19: A management update
      Kathryn Bash, MHSc, MSN, APRN-CNP, Gretchen Sacha, PharmD, BCCCP and Mani Latifi, MD
      Cleveland Clinic Journal of Medicine November 2023, 90 (11) 677-683; DOI: https://doi.org/10.3949/ccjm.90a.22102

      The authors examine current guidelines of the Infectious Diseases Society of America and the National Institutes of Health.

  7. Lindenmeyer, Christina C.

    1. What is the role for terlipressin in hepatorenal syndrome?
      Stephanie N. Bass, PharmD, Aanchal Kapoor, MD and Christina C. Lindenmeyer, MD
      Cleveland Clinic Journal of Medicine November 2023, 90 (11) 664-667; DOI: https://doi.org/10.3949/ccjm.90a.23037

      The drug is recommended as a first-line treatment of hepatorenal syndrome-related acute kidney injury, but it is associated with respiratory failure, especially in the setting of albumin administration, and certain comorbidities may increase the risk.

  8. Mandell, Brian F.

    1. Anchors away
      Brian F. Mandell, MD, PhD
      Cleveland Clinic Journal of Medicine November 2023, 90 (11) 652-653; DOI: https://doi.org/10.3949/ccjm.90b.11023

      Before you read this, I recommend that you read the interesting article in this issue by Prakash et al, part of our Symptoms to Diagnosis series.

  9. Mehdi, Ali

    1. The new GFR equations: How will eliminating the race coefficient affect Black patients?
      Paul Merchant, MD, Crystal Gadegbeku, MD, FAHA, FACP, FASN, Ali Mehdi, MD, Med, FACP, FASN, George Thomas, MD, FACP, Georges Nakhoul, MD, MEd and Jonathan Taliercio, DO, FASN
      Cleveland Clinic Journal of Medicine November 2023, 90 (11) 685-691; DOI: https://doi.org/10.3949/ccjm.90a.22061

      The authors discuss the history of equations for the glomerular filtration rate and potential clinical consequences of the new equations.

  10. Merchant, Paul

    1. The new GFR equations: How will eliminating the race coefficient affect Black patients?
      Paul Merchant, MD, Crystal Gadegbeku, MD, FAHA, FACP, FASN, Ali Mehdi, MD, Med, FACP, FASN, George Thomas, MD, FACP, Georges Nakhoul, MD, MEd and Jonathan Taliercio, DO, FASN
      Cleveland Clinic Journal of Medicine November 2023, 90 (11) 685-691; DOI: https://doi.org/10.3949/ccjm.90a.22061

      The authors discuss the history of equations for the glomerular filtration rate and potential clinical consequences of the new equations.

« Previous (Pages : 1 2 3 4 ... 4) Next »
Back to top

In this issue